Chrys Capital IX would be the largest by an India-specific fund manager

The Irdai's move comes as a major fillip to scores of startups looking for alternative modes of financing, other than foreign private equit...

On November 12, MahaRERA rejected a plea for compensation sought by Ashley Serrao and his father who had purchased a flat in Runwal Greens ...

ChrysCap, which had launched the fundraising in August last year, raised the money in four months, one of the fastest fundraising procedure...

The fund size could go up to $950 million with the firm’s four partners also planning to contribute $50-100 million, the people added.

The new law gives taxmen the right to extract full tax due claims with interest and fines from these people, exposing their personal assets...

ChrysCapital has made 80 investments in India and exited 60 of these since its inception. The fund claims to have realised over $4 billion ...

Home-grown private equity outfit manages $3 billion across its investment portfolio.

ChrysCapital has sold its 11% stake in Mankind Pharma to Capital International for little over $200 million, or Rs 1,300 crore.

As early stage investing emerges as the most active segment of India’s risk capital industry, the size of deals is shrinking.

ChrysCapital, which manages total assets of $2 bn, will also see the exit of Brahmal Vasudevan, one of its managing directors, by year-end.

There have been changes in senior management at the Mudra group with Aniruddha Banerjee being appointed as president of its Mumbai office.